AtriCure, Inc. Passive Investment Disclosure (>5%)
AtriCure Inc reports an institutional holding: Vanguard Capital Management beneficially owns 2,532,965 shares of common stock, representing 5.08% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AtriCure Inc reports an institutional holding: Vanguard Capital Management beneficially owns 2,532,965 shares of common stock, representing 5.08% of the class.
The Schedule 13G lists voting and dispositive powers: sole power to vote 377,201 shares and sole dispositive power over 2,532,965 shares. The filing names affiliated Vanguard entities and is signed by a Vanguard officer.
Insights
Vanguard reports a passive >5% stake with dispositive authority across multiple affiliated accounts.
The filing shows 2,532,965 shares (5.08%) beneficially owned by Vanguard Capital Management and affiliated divisions. The filer reports sole dispositive power over the full holding and sole voting power over 377,201 shares, consistent with consolidated reporting of managed funds.
Because this is a Schedule 13G filing, the position is presented as passive under the filer’s reporting status. Subsequent disclosures would appear if the holder’s intent or voting role changes.
AI-generated analysis. How Rhea-AI works. Not financial advice.